Home Masimo

Masimo

Masimo PVi® Receives FDA Clearance as an Indicator of Fluid Responsiveness on Mechanically Ventilated Patients

PVi, or pleth variability index, is a measure of the dynamic changes in perfusion index that occur during the respiratory cycle.

Masimo SET® Pulse Oximetry New Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening

The authors concluded that “Our results encourage us to strengthen screening for CCHD by adding pulse oximetry to the routine newborn screening panel.”

Masimo Sleep™, a New Wellness Solution That Allows Users to Better Understand Their Sleep Quality

Masimo Sleep analyzes your data to provide truly personalized multi-dimensional insight into your sleep health, empowering you with actionable guidance to help you make healthier lifestyle choices that improve your sleep.

Masimo and MS Westfalia GmbH (MSW) Expand Partnership to Add Masimo SedLine® Brain Function Monitoring, O3® Regional Oximetry, and Oxygen Reserve Index (ORi™) to...

MSW will integrate additional Masimo measurement technologies into MSW’s plug-and-play hybrid Jenny platform, to help clinicians assess brain function, oxygenation, ventilation, and resuscitation status.

Masimo and Mindray Expanded Partnership

Masimo and Mindray have entered into a purchase and license agreement, under which Mindray will offer Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, noninvasive, continuous measurement of oxygen saturation, pulse rate, and perfusion index, in its monitoring devices.

Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology

2/22/19: This latest phase in Saudi Arabia’s national CCHD screening program, which began in 2016 as part of the Vision 2030 plan addressing improvements in healthcare and other areas, automates the collection and storage of screening data, helping to make the process both more efficient and more accurate.

New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration

6/5/18: Dr. Azriel Perel, “In many studies on perioperative and septic patients, the patients who received more fluids seem to have received significantly more blood transfusions. The most probable reason for that is the development of acute dilutional anemia causing the hemoglobin value to decrease below the ‘transfusion threshold.’ This study clearly shows that fluid administration, given as part of the conventional perioperative goal-directed strategy aimed at maximizing the cardiac output, does indeed cause a significant acute decrease of the hemoglobin concentration, leading to a paradoxical decrease in oxygen delivery. This iatrogenic decrease in hemoglobin concentration may cause physicians to administer otherwise avoidable RBC transfusions. Our study also demonstrates that continuous monitoring of hemoglobin (SpHb) through Masimo Pulse CO-Oximetry sensors may detect the development of such iatrogenic hemodilution in real time.”